Researchers take step toward developing cell therapy treatment for MS

An international team has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well tolerated and has a long-lasting effect that appears to protect the brain from further damage.

invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding – Biotech Investments

EQS-News: invIOs GmbH / Key word(s): Study invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant

September 6, 2023

FDA approves high-risk neuroblastoma treatment for kids and adults

The FDA approved US WorldMeds’ eflornithine as a therapy to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma who have

December 15, 2023

TRYP THERAPEUTICS ANNOUNCES SIGNIFICANT MILESTONE IN ITS CLINICAL TRIAL PROGRAM FOR TRP-8803 (IV-INFUSED PSILOCIN) – Biotech Investments

, 01/08/2024 / 07:01, EST/EDT – EQS Newswire – Tryp Therapeutics Inc. (Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Canadian Stock Exchange,

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.